Imagine Institute at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Imagine Institute brings 8 presentations to ESGCT 2026 in Hamburg. Its work centres on genome and base editing for inherited blood disorders such as sickle cell disease and the thalassemias. Other strands engineer AAV capsids that reach kidney podocytes and correct recurrent COL7A1 variants behind a severe skin disease.
| Organization | ESGCT 2026 Attendance |
|---|---|
Imagine Institute Paris, France | |
Paris institute for genetic diseases, with gene therapy and genome editing research for blood disorders such as sickle cell disease. | Talk Tue Oct 27 6:45pm–7:30pm Muscle-targeted and liver detargeted AAV gene therapy provides sustained correction of MSUD in neonatal mice Vectors and delivery (AAV, lentiviral, LNP)Rare and inherited disease Talk Wed Oct 28 9:00am–10:30am Gene Therapy of β-Hemoglobinopathies: Successes and Challenges Rare and inherited disease Poster Wed Oct 28 1:30pm–3:30pm AAV-LK03 Efficiently Transduces Podocytes in Human hiPSC-Derived Kidney Organoids Compared to AAV9 Poster Wed Oct 28 1:30pm–3:30pm AI-guided AAV capsid engineering and multi-modal screening pipeline for targeted podocyte gene therapy Poster Wed Oct 28 1:30pm–3:30pm Development of prime editing strategies for alpha-thalassemia Poster Wed Oct 28 1:30pm–3:30pm Highly efficient correction of two recurrent variants in COL7A1 using Cytosine or Adenine Base editing to treat recessive dystrophic epidermolysis bullosa Chair Thu Oct 29 8:30am–10:30am SESSION 7d: Skin, pulmonary and skeletal diseases Rare and inherited disease Poster Thu Oct 29 2:00pm–4:00pm A multimodal screening pipeline accelerates the discovery of engineered AAV capsids with podocyte tropism Talk Fri Oct 30 9:00am–10:30am Assessing efficacy and safety of genome EDITing approaches for Sickle Cell Disease Gene and epigenome editingRare and inherited disease |
Instantly find 20 buyers from Imagine Institute
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction